Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for shivering and thermoregulation in adults with sepsis
ChiCTR2100052850Phase 4Recruiting
- Sponsor
- Tianjin Fourth Central Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine (2 arms), sponsored by Tianjin Fourth Central Hospital. Primary endpoints: Axillary temperature and Shivering level. Started Oct 2021; status: recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR2100052850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052850.